The European Medicines Agency (EMA), after initial rejection based on an unfavourable risk-benefit balance, recently recommended approval of lecanemab for treating people with mild cognitive ...

Background Cataract surgery has been shown to reduce the risk of developing dementia in the future; however, its impact on ...

New research identifies 17 modifiable factors that can reduce your risk of stroke, dementia, and depression simultaneously, ...